Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
High extracellular inorganic phosphate concentration inhibits RANK–RANKL signaling in osteoclast‐like cells
In this work, we investigated the effect of inorganic phosphate (Pi) on the differentiation of monocyte/macrophage precursors into an “osteoclastic” phenotype, and we delineated the molecular… Expand
Indoxyl sulphate inhibits osteoclast differentiation and function.
- A. Mozar, L. Louvet, +4 authors Z. Massy
- Medicine
- Nephrology, dialysis, transplantation : official…
- 1 June 2012
BACKGROUND
Patients with chronic kidney disease (CKD) develop various bone abnormalities characterized by impaired bone remodelling. Recent data suggest that accumulation of the uraemic toxin indoxyl… Expand
The pathophysiology of vascular calcification: are osteoclast-like cells the missing link?
- Z. Massy, R. Mentaverri, A. Mozar, M. Brazier, Said Kamel
- Biology, Medicine
- Diabetes & metabolism
- 1 February 2008
There is increasing evidence to suggest that the initiation of vascular calcification is an active process involving vascular smooth muscle cell (VSMC) apoptosis and trans-differentiation into… Expand
Tumor Necrosis Factor‐Related Apoptosis‐Inducing Ligand and Vascular Calcification
- Maud Chasseraud, S. Liabeuf, +4 authors S. Kamel
- Medicine
- Therapeutic apheresis and dialysis : official…
- 1 April 2011
Vascular calcification is frequent in patients with chronic kidney disease. Osteoprotegerin (OPG, a soluble factor which blocks osteoclast differentiation) has recently been implicated in the genesis… Expand
Pathophysiological mechanisms and consequences of cardiovascular calcifications: role of uremic toxicity.
- J-M Chillon, A. Mozar, +6 authors Z. Massy
- Medicine
- Annales pharmaceutiques francaises
- 1 July 2009
SUMMARY
Chronic kidney disease (CKD) represents an accelerated model of the active cardiovascular calcification process. Recent data from our laboratory indicate the presence of a possible vascular… Expand
Uremic Toxin Indoxyl Sulfate Inhibits Human Vascular Smooth Muscle Cell Proliferation
- A. Mozar, L. Louvet, +5 authors Z. Massy
- Medicine
- Therapeutic apheresis and dialysis : official…
- 1 April 2011
Uremic syndrome is attributed to the progressive retention of a large number of compounds, such as indoxyl sulfate, which under physiological conditions are excreted by the kidneys. Previous in vitro… Expand
Parathyroid Hormone-Related Peptide (1-36) Enhances Beta Cell Regeneration and Increases Beta Cell Mass in a Mouse Model of Partial Pancreatectomy
- A. Mozar, H. Lin, +6 authors R. Vasavada
- Biology, Medicine
- PloS one
- 8 July 2016
Aims/Hypothesis Finding ways to stimulate the regeneration of endogenous pancreatic beta cells is an important goal in the treatment of diabetes. Parathyroid hormone-related protein (PTHrP), the… Expand
Lactogens protect rodent and human beta cells against glucolipotoxicity-induced cell death through Janus kinase‐2 (JAK2)/signal transducer and activator of transcription-5 (STAT5) signalling
- N. G. Kondegowda, A. Mozar, C. Chin, A. Otero, A. García-Ocaña, R. Vasavada
- Biology, Medicine
- Diabetologia
- 3 March 2012
Aims/hypothesisA leading cause of type 2 diabetes is a reduction in functional beta cell mass partly due to increased beta cell death, triggered by stressors such as glucolipotoxicity (GLT). This… Expand
Systemic and acute administration of parathyroid hormone-related peptide(1–36) stimulates endogenous beta cell proliferation while preserving function in adult mice
- K. Williams, D. Abanquah, +9 authors R. Vasavada
- Biology, Medicine
- Diabetologia
- 29 July 2011
Aims/hypothesisA major focus in the treatment of diabetes is to identify factors that stimulate endogenous beta cell growth while preserving function. The first 36 amino acids of parathyroid… Expand
Growth Factor Mediated Regulation of Beta Cell Survival
- N. G. Kondegowda, X. Zhang, K. Williams, A. Mozar, R. Vasavada
- Biology
- 1 November 2010
Numerous studies have shown that a reduction in the endogenous functional � -cell mass is a major cause of every form of diabetes. Therefore, the development of therapies to preserve and regenerate… Expand